Improvement in Lipids after Switch to Boosted Atazanavir or Darunavir in Children/Adolescents with Perinatally Acquired HIV on Older Protease Inhibitors: Results from the Pediatric HIV/AIDS Cohort Study

BACKGROUND: Dyslipidemia is common in perinatally HIV-infected (PHIV) youth receiving Protease Inhibitors (PIs). Few studies have evaluated longitudinal lipid changes in PHIV youth after switch to newer PIs. METHODS: We compared longitudinal changes in fasting lipids [Total Cholesterol (TC), Triglyc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:HIV Med
Main Authors: Jao, Jennifer, Yu, Wendy, Patel, Kunjal, Miller, Tracie L., Karalius, Brad, Geffner, Mitchell E., DiMeglio, Linda A., Mirza, Ayesha, Chen, Janet S., Silio, Margarita, McFarland, Elizabeth J., Van Dyke, Russell B., Jacobson, Denise
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821593/
https://ncbi.nlm.nih.gov/pubmed/29159965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12566
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados